Effective antibody therapy induces host-protective antitumor immunity that is augmented by TLR4 agonist treatment.
Wang S, Astsaturov IA, Bingham CA, McCarthy KM, von Mehren M, Xu W, Alpaugh RK, Tang Y, Littlefield BA, Hawkins LD, Ishizaka ST, Weiner LM.
Wang S, et al. Among authors: von mehren m.
Cancer Immunol Immunother. 2012 Jan;61(1):49-61. doi: 10.1007/s00262-011-1090-7. Epub 2011 Aug 13.
Cancer Immunol Immunother. 2012.
PMID: 21842208
Free PMC article.